STEM -- StemCells, Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc.

STEM 14.27

+3.0%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WWS who wrote (194)	1/28/1999 8:05:00 AM
From: Jim Oravetz	Read Replies (1) of 805

usnews.com A stem-cell go-ahead National Institutes of Health give an OK to controversial research after legal review ...Well aware that it's walking a political tightrope, the agency plans to set up stringent oversight committees that go above and beyond its traditional peer review process. Despite the months-long wait before the money flows, biologists are delighted. "It'll be a breath of fresh air," says James Robl, a reproductive and developmental biologist at the University of Massachusetts–Amherst. "The time frame from stem cells to therapeutic use is going to be reduced significantly." Sorry if this has been posted already. This is out of the latest issue of US News & World report. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next